On this page
Back to topDanaher DHR
Danaher is the 72nd largest S&P 500 company by market cap, worth $162 billion. Its board has 12 directors, 8 of them independent. 11 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 8.8% of the company.
- CEO
- Rainer Blair
- Chair
- Steven M. Rales
- Sector
- Health CareLife Sciences Tools & Services
- Headquarters
- Washington, D.C.
- Founded
- 1969
- Market cap
- $162B
- 72nd largest, 6 Nov 2026 close
- Price to sales
- 6.6
- Market cap over revenue
- Per employee
- $2.7M
- Market cap over employees
- Connections
- 5
- Companies sharing people
Financials
Latest quarter
Q3 2026 figures from Danaher's earnings release.
Filed 21 Oct 2026
- Revenue
- $6.6B
- Up 8.5% year over year
- Net income
- $1.2B
- Up 35% year over year
Reported figures
Figures from the release, against the same period a year earlier.
| Figure | Value | Change |
|---|---|---|
| Net earnings | $1.2B | +35% |
| Non-GAAP adjusted diluted net earnings per common share | $2.11 | +12% |
| Revenues | $6.6B | +8.5% |
| Non-GAAP core revenue excluding respiratory revenue | 5.5% | - |
| Non-GAAP core revenue | 3% | - |
| Operating cash flow | $1.9B | - |
| Non-GAAP free cash flow | $1.6B | - |
| Net earnings per common share from continuing operations - basic | $1.71 | +34% |
| Net earnings per common share from continuing operations - diluted | $1.71 | +35% |
| Net earnings per common share from discontinued operations - basic | $0.04 | - |
| Net earnings per common share from discontinued operations - diluted | $0.04 | - |
| Net earnings per common share - basic | $1.75 | +37% |
| Net earnings per common share - diluted | $1.75 | +38% |
| Diluted net earnings per common share from continuing operations (GAAP) | $1.71 | +35% |
| Adjusted diluted net earnings per common share from continuing operations (non-GAAP) | $2.11 | +12% |
| Figure | Value | Change |
|---|---|---|
| Biotechnology total sales growth (GAAP) | 0.5% | - |
| Life Sciences total sales growth (GAAP) | 4% | - |
| Diagnostics total sales growth (GAAP) | 17% | - |
| Biotechnology core sales growth (non-GAAP) | 5% | - |
| Life Sciences core sales growth (non-GAAP) | 4.5% | - |
| Diagnostics core sales growth (non-GAAP) | 0.5% | - |
| Diagnostics core sales growth excluding respiratory testing (non-GAAP) | 7% | - |
| Figure | Value | Change |
|---|---|---|
| Non-GAAP core revenue excluding respiratory revenue growth (outlook)Q4 2026 outlook | 4.5% | - |
| Core revenue growth (outlook)Q4 2026 outlook | 3% | - |
| Adjusted diluted net earnings per common share from continuing operations (outlook)Q4 2026 outlook | $8.60 | - |
| Biotechnology core sales growth (outlook)Q4 2026 outlook | 5.5% | - |
| Life Sciences core sales growth (outlook)Q4 2026 outlook | 4.5% | - |
| Diagnostics core sales growth (outlook)Q4 2026 outlook | 0.5% | - |
| Total company core sales growth (outlook)Q4 2026 outlook | 3% | - |
| Impact of respiratory testing on core sales growth (outlook)Q4 2026 outlook | 1.5% | - |
| Core sales growth excluding respiratory testing (outlook)Q4 2026 outlook | 4.5% | - |
| Adjusted operating profit margin (outlook)Q4 2026 outlook | 29.5% | - |
| Impact of currency exchange rates on sales (outlook)Q4 2026 outlook | 0% | - |
| Effective tax rate (outlook)Q4 2026 outlook | 17% | - |
Financial history
Twelve months to 25 Sep 2026, from Danaher's quarterly filings.
Quarters since Dec 2021
- Revenue
- $25.6B
- Up 5.5% on the year before
- Net income
- $4.3B
- 16.9% of revenue
- Free cash flow
- $5.7B
- Operating cash flow less capital spending
- P/E
- 37.4
- Market cap over net income
Quarterly results
Each quarter's revenue, net income and free cash flow.
Dec 2021 to Sep 2026
| Quarter | Revenue | Net income |
|---|---|---|
| Sep 2026 | $6.6B | $1.2B |
| Jun 2026 | $6.3B | $870M |
| Mar 2026 | $6.0B | $1.0B |
| Dec 2025 | $6.8B | $1.2B |
| Sep 2025 | $6.1B | $908M |
| Jun 2025 | $5.9B | $555M |
| Mar 2025 | $5.7B | $954M |
| Dec 2024 | $6.5B | $1.1B |
| Sep 2024 | $5.8B | $818M |
| Jun 2024 | $5.7B | $907M |
| Mar 2024 | $5.8B | $1.1B |
| Dec 2023 | $6.4B | $1.1B |
| Sep 2023 | $6.9B | $1.1B |
| Jun 2023 | $7.2B | $1.1B |
| Mar 2023 | $7.2B | $1.4B |
| Dec 2022 | $8.4B | $2.2B |
| Sep 2022 | $7.7B | $1.6B |
| Jul 2022 | $7.8B | $1.7B |
| Apr 2022 | $7.7B | $1.7B |
| Dec 2021 | $8.1B | $1.8B |
Per employee
Twelve months to 25 Sep 2026, over 60,000 employees in Danaher's latest 10-K.
- Revenue
- $427K
- Operating profit
- $87K
- 20.4% of revenue
- Net income
- $72K
- 16.9% of revenue
Danaher's market cap since December 2008
Weekly, up to 6 Nov 2026
| Week ending | Market cap |
|---|---|
| 6 Nov 2026 | $162B |
| 26 Dec 2025 | $163B |
| 27 Dec 2024 | $167B |
| 29 Dec 2023 | $171B |
| 30 Dec 2022 | $193B |
| 31 Dec 2021 | $235B |
| 25 Dec 2020 | $157B |
| 27 Dec 2019 | $110B |
| 28 Dec 2018 | $71.4B |
| 29 Dec 2017 | $64.6B |
| 30 Dec 2016 | $53.8B |
| 25 Dec 2015 | $64.0B |
| 26 Dec 2014 | $60.9B |
| 27 Dec 2013 | $53.7B |
| 28 Dec 2012 | $38.1B |
| 30 Dec 2011 | $32.3B |
| 31 Dec 2010 | $30.9B |
| 25 Dec 2009 | $24.4B |
| 26 Dec 2008 | $17.5B |
Download Danaher's data as JSON, with the weekly market caps in billions of dollars from 5 Dec 2008.
Board and leadership
Board and officers
3 people here also hold roles at other S&P 500 companies.
Board from the proxy filed 25 Mar 2026; officers filed up to 30 Sep 2026
| Name | Title | Since | Independent | Committees | Age |
|---|---|---|---|---|---|
| Directors (12) | |||||
| Steven M. RalesChairNot independent ยท since 1983 ยท Executive, Finance, Science & Technology | |||||
| Rainer BlairPresident & CEONot independent ยท since 2020 ยท Executive, Finance, Science & TechnologyOther boards: Nestlรฉ | |||||
| Feroz DewanDirectorIndependent ยท since 2022 ยท Finance, Nominating & Governance, Science & TechnologyChief Executive Officer, Arena Holdings Management LLC | |||||
| Linda FillerLead Independent DirectorIndependent ยท since 2005 ยท Nominating & Governance (chair), Science & TechnologyFormer President of Retail Products, Chief Marketing Officer, and Chief Merchandising Officer, Walgreen Co.Also at VeraltoOther boards: The Carlyle Group | |||||
| Charles W. LamannaDirectorIndependent ยท since 2025 ยท Science & TechnologyExecutive Vice President, Agents and Business Apps, Microsoft Corporation | |||||
| Teri ListDirectorIndependent ยท since 2011 ยท Audit, Compensation (chair)Former Executive Vice President and Chief Financial Officer, Gap Inc.Also at Lululemon Athletica, Microsoft and Visa | |||||
| Mitchell P. RalesChairman of Exec. CommitteeNot independent ยท since 1983 ยท Executive (chair), Finance (chair)Other boards: ESAB Corporation | |||||
| A. Shane SandersDirectorIndependent ยท since 2021 ยท Audit (chair), Nominating & GovernanceFormer Senior Vice President of Business Transformation, Verizon Communications Inc.Other boards: Commvault | |||||
| Alan G. SpoonDirectorIndependent ยท since 1999 ยท CompensationFormer Managing General Partner, Polaris PartnersOther boards: Ralliant Corp and IAC | |||||
| Raymond C. StevensDirector | |||||
| Raymond C. Stevens, Ph.D.DirectorIndependent ยท since 2017 ยท Audit, Science & TechnologyChief Executive Officer, Structure TherapeuticsOther boards: Structure Therapeutics | |||||
| Elias A. ZerhouniDirectorIndependent ยท since 2009 ยท Science & Technology (chair), Nominating & GovernancePresident and Vice Chairman, OPKO Health, Inc.Other boards: OPKO Health, Inc. | |||||
| Officers (11) | |||||
| Matthew E. GuginoEVP & Chief Financial OfficerLast filed 6 Aug 2026 | |||||
| Christopher BoudaVP, Chief Accounting OfficerLast filed 6 Aug 2026 | |||||
| Georgeann CoucharaSVP, Human ResourcesLast filed 19 May 2026 | |||||
| Brian W. EllisSenior Vice PresidentAlso at EntergyLast filed 6 Feb 2026 | |||||
| R. Bradley GraySVP Strategic DevelopmentLast filed 3 Mar 2026 | |||||
| Jose-Carlos Gutierrez-RamosSVP, Chief Science OfficerLast filed 6 Aug 2026 | |||||
| Jonathan LeikenSVP-Chief Legal OfficerLast filed 6 Aug 2026 | |||||
| Matthew McGrewExecutive Vice PresidentLast filed 3 Mar 2026 | |||||
| Gregory M. MilosevichExecutive Vice PresidentLast filed 6 Aug 2026 | |||||
| Julie A. Sawyer MontgomeryExecutive Vice PresidentLast filed 6 Aug 2026 | |||||
| Christopher Paul RileyExecutive Vice PresidentLast filed 6 Aug 2026 | |||||
Companies that share people with Danaher
Each person's title here, then at the other company.
- Entergy ETR
- Brian W. Ellis: Senior Vice President here, Director there
- Lululemon Athletica LULU
- Teri List: Director here, Director there
- Microsoft MSFT
- Teri List: Director here, Director there
- Veralto VLTOSame company before a spin-off
- Linda Filler: Lead Independent Director here, Chair there
- Visa V
- Teri List: Director here, Director there
Owners and trading
Largest institutional holders
Each fund group's share of Danaher. Where a company has several share classes, the share is of its total value.
13F filings for the quarter to 30 Jun 2026
Insider trades
Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.
Trades from 6 Nov 2025 to 6 Nov 2026
Directors and officers sold $137 million of stock in 11 sales and made no open-market purchases in the 12 months to 6 Nov 2026.
| Date | Person | Value |
|---|---|---|
| 28 Oct 2026Sale | Matthew McGrewExecutive Vice President | $7.0M |
| 28 Oct 2026Sale | Christopher BoudaVP, Chief Accounting Officer | $1.8M |
| 21 Aug 2026Sale | Rainer BlairPresident & CEO | $13M |
| 1 May 2026Sale | Alan G. SpoonDirector | $237K |
| 19 Feb 2026Sale | Gregory M. MilosevichExecutive Vice President | $275K |
| 25 Nov 2025Sale | Mitchell P. RalesChairman of Exec. Committee | $9.4M |
| 18 Nov 2025Sale | Teri ListDirector | $747K |
| 12 Nov 2025Sale | Mitchell P. RalesChairman of Exec. Committee | $96M |
| 12 Nov 2025Sale | Brian W. EllisSenior Vice President | $4.8M |
| 11 Nov 2025Sale | Matthew McGrewExecutive Vice President | $3.5M |
Showing 10 of 11 trades
Trades by members of Congress and officials
Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.
Trades from 27 Oct 2023 to 27 Oct 2026
24 people disclosed 53 purchases and 40 sales of Danaher stock since October 2023.
| Date | Member or official | Amount |
|---|---|---|
| 2 Sep 2026 | Kevin HernHouse, R-OK ยท Sold | $1K to $15K |
| 31 Aug 2026 | Kevin HernHouse, R-OK ยท Sold | $15K to $50K |
| 23 Jul 2026 | Donald J TrumpPresident ยท Bought | $100K to $250K |
| 23 Jun 2026 | Donald J TrumpPresident ยท Bought | $1K to $15K |
| 16 Jun 2026 | Michael T. McCaulHouse, R-TX ยท Bought | $1K to $15K |
| 5 Jun 2026 | Michael T. McCaulHouse, R-TX ยท Bought | $1K to $15K |
| 3 Jun 2026 | Michael T. McCaulHouse, R-TX ยท Bought | $1K to $15K |
| 2 Jun 2026 | Rohit KhannaHouse, D-CA ยท Bought | $15K to $50K |
| 2 Jun 2026 | Michael T. McCaulHouse, R-TX ยท Bought | $1K to $15K |
| 22 May 2026 | Donald J TrumpPresident ยท Sold | $15K to $50K |
Showing 10 of 93 trades
Workforce and hiring
Workforce
Headcount at 31 Dec 2025
- Employees
- 60,000
Employees, last 10 fiscal years
Down 13% in five years, from 69,000 in 2020 to 60,000 in 2025.
As of December 31, 2025, the Company had approximately 60,000 employees (whom we refer to as โassociatesโ), of whom approximately 22,000 were employed in North America, 20,000 in Western Europe, 3,000 in other developed markets and 15,000 in high-growth markets.
WARN layoff notices
Notices filed under Danaher's own name or a subsidiary's listed in its 10-K.
Notices from 7 Nov 2023 to 7 Nov 2026
Danaher filed 20 notices covering 888 workers since November 2023.
| Notice | Place | Workers |
|---|---|---|
| 13 Mar 2025 | Sunnyvale, CA | 61 |
| 13 Mar 2025 | Lodi, CA | 33 |
| 13 Mar 2025 | Sunnyvale, CA | 24 |
| 13 Mar 2025 | Lodi, CA | 8 |
| 13 Mar 2025 | Lodi, CA | 7 |
| 13 Mar 2025 | Santa Clara, CA | 7 |
| 13 Mar 2025 | Newark, CA | 6 |
| 13 Mar 2025 | Lodi, CA | 5 |
| 13 Mar 2025 | Sunnyvale, CA | 4 |
| 13 Mar 2025 | Fremont, CA | 3 |
Showing 10 of 20 notices
Timeline
Leadership changes, layoffs and insider sales
7 Nov 2024 to 7 Nov 2026; insider sales from 6 Nov 2025
8 departures and 6 appointments of directors and officers, WARN layoff notices on 1 day and 8 large insider sales in the last two years.
Insider sales of $1 million or more, and the largest tenth of Danaher's insider sales.
Events, newest first
- 28 Oct 2026 Matthew McGrew sold $7.0MExecutive Vice President
- 28 Oct 2026 Christopher Bouda sold $1.8MVP, Chief Accounting Officer
- 9 Oct 2026 Alan G. Spoon retiredMember of the Board
- 9 Oct 2026 Robert M. Hershberg appointedDirector
- 9 Oct 2026 Daniel L. Comas appointedDirector
- 21 Aug 2026 Rainer Blair sold $13MPresident & CEO
- 31 Jul 2026 Rainer M. Blair resignedMember of the Board, effective 1 Oct 2026
- 31 Jul 2026 Rainer M. Blair resignedPresident and CEO, effective 1 Oct 2026
Showing 8 of 23 events
| Date | Event | Filing |
|---|---|---|
| 28 Oct 2026 | Matthew McGrew sold $7.0MExecutive Vice President | Form 4 |
| 28 Oct 2026 | Christopher Bouda sold $1.8MVP, Chief Accounting Officer | Form 4 |
| 9 Oct 2026 | Alan G. Spoon retiredMember of the Board | 8-K |
| 9 Oct 2026 | Robert M. Hershberg appointedDirector | 8-K |
| 9 Oct 2026 | Daniel L. Comas appointedDirector | 8-K |
| 21 Aug 2026 | Rainer Blair sold $13MPresident & CEO | Form 4 |
| 31 Jul 2026 | Rainer M. Blair resignedMember of the Board, effective 1 Oct 2026 | 8-K |
| 31 Jul 2026 | Rainer M. Blair resignedPresident and CEO, effective 1 Oct 2026 | 8-K |
| 31 Jul 2026 | Julie Sawyer Montgomery appointedDirector, effective 1 Oct 2026 | 8-K |
| 31 Jul 2026 | Julie Sawyer Montgomery appointedPresident and Chief Executive Officer, effective 1 Oct 2026 | 8-K |
| 5 Feb 2026 | Jessica L. Mega retiredBoard of Directors | 8-K |
| 25 Nov 2025 | Mitchell P. Rales sold $9.4MChairman of Exec. Committee | Form 4 |
| 12 Nov 2025 | Mitchell P. Rales sold $96MChairman of Exec. Committee | Form 4 |
| 12 Nov 2025 | Brian W. Ellis sold $4.8MSenior Vice President | Form 4 |
| 11 Nov 2025 | Matthew McGrew sold $3.5MExecutive Vice President | Form 4 |
| 10 Nov 2025 | Georgeann Couchara sold $1.1MSVP, Human Resources | Form 4 |
| 6 Nov 2025 | John T. Schwieters did not stand for re-electionDirector | 8-K |
| 28 Jul 2025 | Brian W. Ellis leftGeneral Counsel, effective 25 Aug 2025 | 8-K |
| 21 Jul 2025 | Matthew M. McGrew resignedChief Financial Officer, effective 28 Feb 2026 | 8-K |
| 21 Jul 2025 | Matthew E. Gugino appointedExecutive Vice President-Chief Financial Officer, effective 28 Feb 2026 | 8-K |
| 13 Mar 2025 | 167 workers in 5 places14 notices, effective 12 May 2025 | WARN |
| 20 Feb 2025 | Charles W. Lamanna appointedDirector | 8-K |
| 9 Dec 2024 | Pardis C. Sabeti retiredDirector, effective 10 Dec 2024 | 8-K |
Not on file: no open roles from its careers site yet.